Physician profile
Robert Thain
NPI 1285737213
$7,680.36
in general payments reported to CMS, 2019-2025
33 companies · $570 in 2025
The $570 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,876 · 2020: $1,111 · 2021: $1,302 · 2022: $1,314 · 2023: $1,216 · 2024: $291 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,225.47 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $929.22 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $918.73 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $787.36 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $637.60 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $556.35 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $366.42 | 2021-2025 | Vraylar |
| Pfizer INC. | $321.56 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $292.69 | 2019-2023 | |
| Mylan Specialty L.P. | $245.73 | 2019-2023 | Yupelri |
| Janssen Pharmaceuticals, INC | $220.11 | 2019-2025 | Spravato |
| Merck Sharp & Dohme LLC | $194.53 | 2019-2022 | |
| Abbott Laboratories | $145.32 | 2020-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.09 | 2019-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $124.29 | 2019-2023 | Eliquis |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $80.45 | 2021-2023 | Injectafer |
| Dexcom, INC. | $56.01 | 2022-2023 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $48.16 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.42 | 2023 | Xifaxan |
| Exact Sciences Corporation | $42.35 | 2025 | The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $36.26 | 2021 | |
| Allergan, INC. | $34.02 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.01 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.68 | 2021-2022 | |
| Astellas Pharma US INC | $28.29 | 2019-2024 | Veozah |
| Philips North America LLC | $26.65 | 2022-2023 | |
| Amarin Pharma, INC. | $23.28 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.73 | 2022 | |
| Tris Pharma INC | $18.22 | 2024 | Dyanavel Xr |
| Viatris Specialty LLC | $17.69 | 2025 | Yupelri |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.16 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.91 | 2023 | Quviviq |
| Medtronic Minimed, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.